Sarcoma  >>  pegylated liposomal doxorubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00002985: Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Completed
3
US
daunorubicin hydrochloride, pegylated liposomal doxorubicin hydrochloride
Roswell Park Cancer Institute
Sarcoma
01/07
 
NCT00003350: Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma

Completed
3
240
US
paclitaxel, Anzatax, Asotax, TAX, Taxol, pegylated liposomal doxorubicin hydrochloride, CAELYX, Dox-SL, DOXIL, doxorubicin hydrochloride liposome, LipoDox, laboratory biomarker analysis, quality-of-life assessment, quality of life assessment
National Cancer Institute (NCI)
AIDS-related Kaposi Sarcoma
03/07
 
NCT05411237: Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

Not yet recruiting
3
130
NA
Pegylated liposomal doxorubicin, Doxil, Paclitaxel, Taxol
AIDS Malignancy Consortium, National Cancer Institute (NCI)
Kaposi Sarcoma, HIV-1-infection, AIDS-related Kaposi Sarcoma
12/27
09/28
PDVPSTS, NCT03342300: Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Withdrawn
2/3
0
RoW
pegylated liposomal doxorubicin, pirarubicin
Peking University People's Hospital, Peking University Shougang Hospital, Chinese PLA General Hospital, Beijing Jishuitan Hospital, Xijing Hospital, Peking Union Medical College Hospital
Progression-free Survival, Overall Survival, Toxicity
11/20
12/20

Download Options